Cargando…
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia
BACKGROUND: Patients with schizophrenia have lower longevity than the general population as a consequence of a combination of risk factors connected to the disease, lifestyle and the use of medications, which are related to weight gain. METHODS: A multicentric, randomized, controlled-trial was condu...
Autores principales: | Attux, Cecília, Martini, Larissa C, Elkis, Hélio, Tamai, Sérgio, Freirias, Andréa, Camargo, Maria das Graças Miquelutti, Mateus, Mário Dinis, Mari, Jair de Jesus, Reis, André F, Bressan, Rodrigo A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599931/ https://www.ncbi.nlm.nih.gov/pubmed/23418863 http://dx.doi.org/10.1186/1471-244X-13-60 |
Ejemplares similares
-
Schizophrenia and work: aspects related to job acquisition in a follow-up study
por: Martini, Larissa C., et al.
Publicado: (2017) -
M184. SOCIAL SKILLS TRAINING FOR TREATMENT-RESISTANT SCHIZOPHRENIA WITH PREDOMINANTLY NEGATIVE SYMPTOMS
por: Kayo, Monica, et al.
Publicado: (2020) -
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã, Mário Rodrigues, et al.
Publicado: (2011) -
Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
por: Koga, Gabriela, et al.
Publicado: (2022) -
F119. MULTILEVEL ANALYSIS IMPROVES THE MODEL FIT OF THE DIMENSIONAL STRUCTURE OF THE PANSS IN PATIENTS WITH SCHIZOPHRENIA
por: Higuchi, Cinthia, et al.
Publicado: (2018)